Hester Biosciences Ltd. Earnings/Conference Calls

Hester Biosciences Ltd. earnings concalls and investor presentations

Load latest

Hester Biosciences Ltd.

29 Jun 2020

1747.60

6.20%

Earnings Call

HESTER BIOSCIENCES LTD. - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

We hereby submitting a transcript of Earnings Conference Call held by the Management of the Company with investors on Friday, 26.06.2020 at 2:00 p.m. to discuss the Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31.03.2020, for your information and record.

pdf

Hester Biosciences Ltd.

26 Jun 2020

1747.60

6.20%

Earnings Call Transcript - Q4FY20 for Hester Biosciences

Conference Call with Hester Biosciences Management and Analysts on Q4FY20 and Full Year Earnings Performance and Outlook. Listen to the full earnings transcript.

Hester Biosciences Ltd.

10 Feb 2020

1747.60

6.20%

Earnings Call

Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

We hereby submitting a transcript of Earnings Conference Call held by the Management of the Company with investors on Friday, 7 February 2020 at 2.00 p.m. to discuss the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended on 31 December 2019, for your information and record.

pdf

Hester Biosciences Ltd.

19 Nov 2019

1747.60

6.20%

Earnings Call

Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

We hereby submitting a transcript of Earnings Conference Call held by the Management of the Company with investors on 6 November 2019 at 2.00 p.m. to discuss the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended on 30 September 2019, for your information and record.

pdf

Hester Biosciences Ltd.

02 Aug 2019

1747.60

6.20%

Earnings Call

Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

We hereby submitting a transcript of Earnings Conference Call held by the Management of the Company with investors on 31 July 2019 at 2.30 p.m. to discuss the Standalone and Consolidated Unaudited Financial Results for the quarter ended on 30 June 2019, for your information and record.

pdf

Hester Biosciences Ltd.

01 Nov 2018

1747.60

6.20%

Earnings Call

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

We have submitted Transcript of earnings conference call on 31 October 2018 to the exchange, there is a minor correction in transcript on the page no. 15, first line to be read as 'Tanzania is $18 million project, $4 million is our equity and the rest is coming from the Gate foundation.' instead of 'Tanzania is $80 million project, $4 million is our loan and the rest is coming from the Gate foundation.' Please find corrected transcript of earnings conference call as attached herewith.

pdf

Hester Biosciences Ltd.

31 Oct 2018

1747.60

6.20%

Earnings Call

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

We hereby submitting a transcript of Earnings Conference Call held by the Management of the Company with investors on 29 October 2018 at 2.00 p.m. to discuss the Unaudited Standalone Financial Results for the quarter and half year ended on 30 September 2018, for your information and record.

pdf

Hester Biosciences Ltd.

13 Aug 2018

1747.60

6.20%

Earnings Call

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Transcript of Earnings Conference Call held by the Management of the Company with investors on 10 August 2018 at 2.30 p.m. to discuss the Unaudited Standalone Financial Results for the quarter ended on 30 June 2018

pdf

Hester Biosciences Ltd.

16 May 2018

1747.60

6.20%

Earnings Call

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Transcript of Earnings Conference Call held by the Management of the Company with investors on 14 May 2018 at 2.00 p.m. to discuss the Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31 March 2018

pdf

Hester Biosciences Ltd.

25 Jan 2018

1747.60

6.20%

Earnings Call

Analyst / Investor Meet - Outcome

BSE India

Transcript of Earnings Conference Call held by the Management of the Company with investors on Tuesday, 23 January 2018 at 2.00 p.m. to discuss the Unaudited Standalone Financial Results for the quarter ended on 31 December 2017

pdf

Is Hester Biosciences Ltd. worth buying?

80 Votes:

Buy 80.0%

Sell 11.25%

Hold 8.75%